𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy

✍ Scribed by Toni K. Choueiri; Meredith M. Regan; Jonathan E. Rosenberg; William K. Oh; Jessica Clement; Angela M. Amato; David McDermott; Daniel C. Cho; Michael B. Atkins; Sabina Signoretti

Book ID
110922764
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
499 KB
Volume
106
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical factors associated with outcome
Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to